Electron beam computed tomography: calcification and lipid lowering interventions

Area of Science:

• Cardiovascular Medicine
• Atherosclerosis Research

Background:

• Over 50% of myocardial infarctions result in sudden death, often without prior warning.
• Preclinical atherosclerosis identification is vital to prevent angina, myocardial infarction (MI), stroke, and death.
• Primary prevention strategies could avert over 100,000 premature deaths annually in the US and 10 times that globally.

Purpose of the Study:

• Investigate new methods for detecting atherosclerotic plaque burden and morphology.
• Evaluate endothelial function as a marker for cardiovascular disease.
• Assess the potential of novel therapies for coronary artery disease (CAD) prevention and treatment.

Main Methods:

• Review of multiple clinical trials on cholesterol reduction therapies (statins).
• Exploration of emerging therapeutic strategies including antibiotics, antioxidants, and angiogenesis medications.
• Focus on non-invasive modalities for tracking atherosclerosis progression or regression.

Main Results:

• Cholesterol reduction therapies (diet with statins) demonstrate reproducible mortality benefits in primary and secondary prevention.
• New therapeutic agents are being introduced for potential CAD prevention and treatment.
• Non-invasive tracking of atherosclerosis is key for evaluating therapeutic efficacy.

Conclusions:

• Early identification of individuals with preclinical atherosclerosis is essential for effective primary prevention.
• Cholesterol-lowering medications significantly improve mortality rates.
• Advancements in non-invasive imaging and novel therapies hold promise for managing and potentially reversing atherosclerosis.